AS 1403
Alternative Names: TheraFabLatest Information Update: 08 Sep 2003
At a glance
- Originator Antisoma
- Class Antineoplastics; Fab fragments; Monoclonal antibodies; Radiopharmaceuticals
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Lung cancer; Non-small cell lung cancer
Most Recent Events
- 08 Sep 2003 Discontinued - Phase-I for Lung cancer in United Kingdom (IV)
- 08 Sep 2003 Discontinued - Phase-I for Non-small cell lung cancer in Australia (IV)
- 08 Sep 2003 Discontinued - Phase-I for Non-small cell lung cancer in Europe (IV)